Study Suggests Long-Term Melatonin Use May Up Heart Failure Risk
A recent study has uncovered a potential link between long-term melatonin use and an increased risk of heart failure. Researchers have found that adults who took the over-the-counter sleep aid for at least one year were nearly 89% more likely to develop heart failure compared to those who did not use melatonin.
The study, which examined medical records from 130,828 adults diagnosed with insomnia, also revealed that users of melatonin had a significantly higher chance of being hospitalized for heart failure and dying from any cause. Specifically, the melatonin group was nearly three and a half times more likely to be hospitalized for heart failure and almost twice as likely to die.
The findings have raised concerns about the safety of widely used sleep aids, with one researcher warning that "melatonin supplements may not be as harmless as commonly assumed." The study's lead author notes that if these findings are confirmed, it could significantly impact how doctors counsel patients about sleep aids.
While the association between melatonin use and heart failure is intriguing, researchers acknowledge several limitations to their study. They did not have access to information on the severity of subjects' insomnia or their histories with other psychiatric disorders, which makes categorization of groups more complicated due to differences in regulation across countries such as the US and UK.
More research is needed to test melatonin's safety for the heart and determine whether there is a direct cause-and-effect relationship between long-term use and an increased risk of heart failure.
A recent study has uncovered a potential link between long-term melatonin use and an increased risk of heart failure. Researchers have found that adults who took the over-the-counter sleep aid for at least one year were nearly 89% more likely to develop heart failure compared to those who did not use melatonin.
The study, which examined medical records from 130,828 adults diagnosed with insomnia, also revealed that users of melatonin had a significantly higher chance of being hospitalized for heart failure and dying from any cause. Specifically, the melatonin group was nearly three and a half times more likely to be hospitalized for heart failure and almost twice as likely to die.
The findings have raised concerns about the safety of widely used sleep aids, with one researcher warning that "melatonin supplements may not be as harmless as commonly assumed." The study's lead author notes that if these findings are confirmed, it could significantly impact how doctors counsel patients about sleep aids.
While the association between melatonin use and heart failure is intriguing, researchers acknowledge several limitations to their study. They did not have access to information on the severity of subjects' insomnia or their histories with other psychiatric disorders, which makes categorization of groups more complicated due to differences in regulation across countries such as the US and UK.
More research is needed to test melatonin's safety for the heart and determine whether there is a direct cause-and-effect relationship between long-term use and an increased risk of heart failure.